Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-06 2024-03-15 209286
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-26 212362
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-01 2024-02-02 212368
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-12 212371
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-05 212392
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-08 2024-01-19 212969
APO-DARIFENACIN 7.5MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-15 2024-02-02 213547
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-26 214241
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-19 2024-02-09 216662
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-22 216687

Showing 2981 to 3000 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LAMIVUDINE HBV 100MG TABLET Discontinued 2018-09-07 2019-12-21 60563
APO-LEVOCARB - TAB 25MG/250MG 25MG 250MG TABLET Discontinued 2018-09-07 2019-02-07 60576
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-LISINOPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-26 60582
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-07 2018-12-28 60600
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-MEDROXY TABLETS 2.5MG TABLET Discontinued 2018-09-07 2018-09-15 60609
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-METOPROLOL 50MG TABLET Discontinued 2018-09-07 2019-01-09 60631
APO-METOPROLOL (TYPE L) 50MG TABLET Discontinued 2018-09-07 2019-02-02 60634
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640

Showing 221 to 240 of 356